Detailed narrative
Strong Q1 Performance and Guidance Raise
RadNet achieved record Q1 revenue of $428.4 million and adjusted EBITDA of $68.1 million, representing year-over-year increases of 22.1% and 36.3% respectively. This performance was delivered despite an estimated $13 million revenue and $9 million adjusted EBITDA negative impact from severe weather in January and February. The strong operational results, particularly in March and early May, led management to raise its full-year 2026 guidance for imaging center revenue, adjusted EBITDA, and free cash flow.
Shift Towards Advanced Imaging
The company continues to observe a significant industry-wide shift towards advanced imaging, which now constitutes 29.3% of its procedural volume, a 235 basis point increase from the prior year. Same-center MRI volume grew 10.1%, and PET/CT procedures saw a 14.7% increase on a same-center basis, driven by studies for prostate cancer and neurodegenerative diseases. This trend is bolstered by RadNet's strategic capital investments in advanced imaging equipment and the implementation of DeepHealth's remote scanning solution, TechLive, which enhances throughput and capacity.
Strategic Acquisitions and Integration
RadNet completed two notable imaging center acquisitions in January: Radiology Regional, comprising 13 multimodality centers in Southwest Florida, and Northwest Radiology, with 6 centers in the Indianapolis area, marking the company's entry into Indiana. Additionally, the Digital Health division acquired Gleemer SAS in France on March 2, a developer of FDA-cleared and CE Mark AI solutions for musculoskeletal, breast, lung, and neurologic applications. Integration efforts are actively underway to deploy DeepHealth AI solutions across these new operations, aiming to improve clinical accuracy, streamline processes, and enhance patient outcomes.
Growing Joint Venture Business
The hospital and health system joint venture business continues its expansion, highlighted by a new partnership with Trinity Health’s Saint Alphonsus Health System in Boise, Idaho, announced on April 30. This venture, which will initially operate 5 centers and generate approximately $30 million in annual revenues, saw RadNet acquire a 51% interest for about $17 million. With this addition, 155 of RadNet's 440 centers, or 35.2%, are now part of health system partnerships, underscoring the increasing demand from hospitals for cost-effective outpatient imaging solutions.
Digital Health Momentum and AI Initiatives
DeepHealth's momentum is accelerating, with its Annual Recurring Revenue (ARR) reaching $97 million, representing a 95% year-over-year growth, and is on track to exceed $140 million by year-end. The company is evolving its offering from point solutions to an enterprise solution that integrates clinical AI, image management, and reporting. DeepHealth and third-party AI solutions now cover over 70% of RadNet's studies, yielding tangible productivity gains, such as a 33% efficiency increase in thyroid ultrasound slot times by reducing scan times from 30 to 20 minutes.
Financial Strength and Working Capital Efficiency
RadNet maintained a strong financial position, ending the quarter with a cash balance of $455.3 million and full availability of its $282 million revolving credit facility. Significant improvements in revenue cycle management, particularly in patient collections, resulted in a record low of 29.5 days sales outstanding (DSOs). This enhanced working capital efficiency provides substantial cash flow to support the company's ongoing growth and expansion initiatives across both its imaging center and digital health segments.